# Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein

@article{Goedert2015AlzheimersAP,
title={Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled A$\beta$, tau, and $\alpha$-synuclein},
author={Michel Goedert},
journal={Science},
year={2015},
volume={349}
}
• M. Goedert
• Published 7 August 2015
• Biology, Medicine
• Science
Converging paradigms in neurodegeneration Parkinson's disease and Alzheimer's disease are progressive neurodegenerative diseases with increasing prevalence in our aging populations. Recent evidence suggests that some of the molecular mechanisms involved in the pathology of these diseases have similarities to those observed in infectious prion diseases such as bovine spongiform encephalopathy (mad cow disease). Goedert reviews how the spread of a variety of pathological protein aggregates is… Expand
571 Citations

#### Topics from this paper

One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.
• Medicine, Biology
• Progress in molecular biology and translational science
• 2020
A new reading frame for AD pathophysiology is generated, based on the application of the prion paradigm to the amyloid cascade hypothesis in an attempt to definitely explain the key events causing the disease and inducing its occurrence under different clinical phenotypes. Expand
Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
• Medicine
• Biomolecules
• 2021
A historical perspective on the unique transmissible nature of prion diseases is provided, examining their impact on public health and the ongoing concerns raised by this rare group of disorders. Expand
Interactions of pathological proteins in neurodegenerative diseases
• Medicine
• Acta Neuropathologica
• 2017
It is concluded that there is evidence for interactions at the molecular level as well as for additive effects on brain damage by multiple pathologies occurring in different functionally important neurons. Expand
Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells
It is demonstrated that prion propagation in HEK cells requires isoform pairing between the infecting prion and the recipient substrate, and increasing the level of 4R isoform expression alone supported the propagation of both AD and CTE prions. Expand
Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
The current knowledge of the molecular and cellular biology of AD and also the mechanisms that underlie Aβ-mediated neurodegeneration are summarized and discussed. Expand
Molecular Mechanisms in the Pathogenesis of Alzheimer’s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation
Intervention in the conversion of normal tau to abnormal forms and in cell-to-cell transmission of tau may be the key to development of disease-modifying therapies for AD and other dementing disorders. Expand
Strains of Pathological Protein Aggregates in Neurodegenerative Diseases
The pathobiology of prion strains is outlined and how the concept of protein aggregate strains may help to explain the heterogeneity inherent to many human neurodegenerative disorders is discussed. Expand
α-synuclein in the pathophysiology of Alzheimer’s disease
• Medicine
• Molecular Neurodegeneration
• 2019
A summary of the current evidence proposing an involvement of αSyn either as an active or passive player in the pathophysiological ensemble of AD is provided, and the current knowledge of α synuclein structure and inferred function is described. Expand
α-Synuclein and tau, two targets for dementia
• Medicine
• 2020
Both covalent and noncovalent inhibitors targeting alpha-synuclein and tau targeting Alzheimer's disease and Parkinson's disease with dementia are discussed. Expand
Role of viruses, prions and miRNA in neurodegenerative disorders and dementia
Comprehensive understandings of the expression profiles and activities of these miRNAs, Prions, Viruses will illuminate their roles as potential therapeutic targets in neurodegeneration and may lead to the discovery of breakthrough treatment strategies for neurodegnerative disorders and dementia. Expand

#### References

SHOWING 1-10 OF 182 REFERENCES
Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients
• J. Watts, +7 authors S. Prusiner
• Biology, Medicine
• Proceedings of the National Academy of Sciences
• 2014
It is concluded that at least two distinct strains of Aβ prions can be discerned in the brains of Alzheimer’s disease patients and that strain fidelity was preserved on serial passage in mice. Expand
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
The common late-onset form of Alzheimer's disease is characterized by an overall impairment in Aβ clearance, and both Aβ42 and Aβ40 production and clearance rates were impaired in Alzheimer’s disease compared with controls. Expand
Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice
• J. Stöhr, +7 authors S. Prusiner
• Biology, Medicine
• Proceedings of the National Academy of Sciences
• 2014
It is concluded that the composition of Aβ plaques depends on the conformation of the inoculated Aβ polymers, and thus, these inocula represent distinct synthetic Aβ prion strains. Expand
A Century of Alzheimer's Disease
• Biology, Medicine
• Science
• 2006
The ongoing molecular dissection of the neurodegenerative pathways is expected to lead to a true understanding of disease pathogenesis. Expand
Prion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies
• Biology, Medicine
• Current Neurology and Neuroscience Reports
• 2014
It is now believed that protein aggregates form in a small number of brain cells, from which they propagate intercellularly through templated recruitment, reminiscent of the mechanisms by which prions spread through the nervous system. Expand
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
• Biology, Medicine
• Nature
• 2013
As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases. Expand
Abnormal tau-containing filaments in neurodegenerative diseases.
• Biology, Medicine
• Journal of structural biology
• 2000
These diseases show that tau mutations can be a prime cause of inherited dementing illness and may throw some light on the pathological process in the much larger number of sporadic cases of Alzheimer's disease. Expand
A three-dimensional human neural cell culture model of Alzheimer’s disease
This work reports that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloids-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system, and successfully recapitulated Alzheimer’s disease pathology in a single 3D human neural cell culture system. Expand
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
The strong protective effect of the A673T substitution against Alzheimer’s disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease. Expand
A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology
The results suggest that the novel SNCA A53E substitution is a causative mutation resulting clinically in parkinsonism and pathologically in severe multiple system atrophy- and PD-type phenotype. Expand